DNLI
Denali Therapeutics Inc

1,768
Mkt Cap
$2.65B
Volume
505,006.00
52W High
$24.35
52W Low
$10.57
PE Ratio
-5.84
DNLI Fundamentals
Price
$16.99
Prev Close
$16.81
Open
$16.90
50D MA
$17.22
Beta
1.57
Avg. Volume
1.44M
EPS (Annual)
-$2.57
P/B
2.69
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Marex Group plc Takes $3.67 Million Position in Denali Therapeutics Inc. $DNLI
Marex Group plc acquired a new stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) in the second quarter, according to the company in its most recent disclosure with the...
MarketBeat·12d ago
News Placeholder
More News
News Placeholder
Camber Capital Management LP Has $5.60 Million Position in Denali Therapeutics Inc. $DNLI
Camber Capital Management LP cut its holdings in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 68.0% in the second quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·14d ago
News Placeholder
Wedbush Issues Pessimistic Forecast for Denali Therapeutics (NASDAQ:DNLI) Stock Price
Wedbush lowered their target price on Denali Therapeutics from $31.00 to $30.00 and set an "outperform" rating on the stock in a research report on Thursday...
MarketBeat·15d ago
News Placeholder
Denali Therapeutics (NASDAQ:DNLI) Shares Gap Down - Here's What Happened
Denali Therapeutics (NASDAQ:DNLI) Shares Gap Down - Here's What Happened...
MarketBeat·15d ago
News Placeholder
Marshall Wace LLP Sells 783,172 Shares of Denali Therapeutics Inc. $DNLI
Marshall Wace LLP lessened its holdings in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 35.8% during the second quarter, according to the company in its most recent filing with...
MarketBeat·17d ago
News Placeholder
BTIG Research Reiterates Buy Rating for Denali Therapeutics (NASDAQ:DNLI)
BTIG Research restated a "buy" rating and issued a $32.00 price objective on shares of Denali Therapeutics in a research note on Friday...
MarketBeat·20d ago
News Placeholder
3,947,387 Shares in Denali Therapeutics Inc. $DNLI Acquired by Norges Bank
Norges Bank purchased a new stake in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and...
MarketBeat·20d ago
News Placeholder
Denali Enters Into a $275M Funding Deal With Royalty Pharma
DNLI secures a $275M funding deal with Royalty Pharma tied to potential approvals for its Hunter syndrome therapy.
Zacks·21d ago
News Placeholder
Schroder Investment Management Group Purchases 94,744 Shares of Denali Therapeutics Inc. $DNLI
Schroder Investment Management Group increased its position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 32.5% during the 2nd quarter, according to the company in its most...
MarketBeat·21d ago
News Placeholder
Denali Therapeutics Inc. (NASDAQ:DNLI) Receives Consensus Rating of "Buy" from Brokerages
Denali Therapeutics Inc. (NASDAQ:DNLI - Get Free Report) has been assigned a consensus recommendation of "Buy" from the sixteen ratings firms that are currently covering the stock, MarketBeat.com...
MarketBeat·25d ago
<
1
2
...
>

Latest DNLI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.